Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CYH
CYH logo

CYH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Community Health Systems Inc (CYH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.940
1 Day change
2.44%
52 Week Range
4.460
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Community Health Systems Inc (CYH) does not present a compelling buy opportunity for a beginner investor with a long-term strategy at this time. The technical indicators are bearish, the financial performance is weak, and there are no significant positive catalysts or trading signals to support an immediate investment.

Technical Analysis

The technical indicators for CYH are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 31.171, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support is at 2.867, with resistance at 3.045. The stock is trading below its pivot point, suggesting further downside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
5

Positive Catalysts

  • The gross margin increased by 2.00% YoY in Q4 2025, indicating some operational efficiency improvements.

Neutral/Negative Catalysts

  • Analysts have mixed ratings, with some maintaining neutral or underweight ratings and lowering price targets. There is no recent news or significant insider/hedge fund activity to suggest a positive outlook.

Financial Performance

In Q4 2025, CYH reported a revenue decline of 4.87% YoY to $3.106 billion. Net income dropped significantly by 257.14% YoY to $110 million, and EPS fell by 252.83% YoY to 0.81. However, the gross margin increased slightly by 2.00% YoY to 82.13.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views on CYH. UBS raised the price target to $3.70 (Neutral), Truist raised it to $4.50 (Hold), while Wells Fargo lowered it to $2 (Underweight). The sentiment reflects uncertainty in the hospital sector due to post-COVID challenges and legislative risks.

Wall Street analysts forecast CYH stock price to rise
3 Analyst Rating
Wall Street analysts forecast CYH stock price to rise
1 Buy
1 Hold
1 Sell
Hold
Current: 2.870
sliders
Low
2
Averages
3.67
High
5
Current: 2.870
sliders
Low
2
Averages
3.67
High
5
UBS
Neutral
maintain
AI Analysis
2026-02-20
Reason
UBS
Price Target
AI Analysis
2026-02-20
maintain
Neutral
Reason
UBS raised the firm's price target on Community Health to $3.70 from $3.60 and keeps a Neutral rating on the shares.
Wells Fargo
Underweight
downgrade
$3 -> $2
2026-01-07
Reason
Wells Fargo
Price Target
$3 -> $2
2026-01-07
downgrade
Underweight
Reason
Wells Fargo lowered the firm's price target on Community Health to $2 from $3 and keeps an Underweight rating on the shares. For managed care organizations, the firm is most constructive on Medicare Advantage with uncertainty high for Medicaid/Exchanges. Wells sees a more difficult backdrop for hospitals in 2026 as post-COVID tailwinds wane and legislative risks near. Distributor debate remains revisions vs. multiples.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CYH
Unlock Now

People Also Watch